Doctor profile · Federal record
Dr. Sarah Riley, PA-C
Physician Assistant · Marietta, GA
- NPI 1790338762
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
835 Cogburn Avenue, Suite 100
Marietta, GA 300601008
(770) 422-5557
fax (770) 422-5456
Credentials & registration
- NPI registered
- July 2019 — 7 yrs on file
- Profile last updated
- June 15, 2020
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Georgia #9309
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790338762. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,353
Distinct HCPCS
10
Medicare allowed
$120,480
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 820 | 160 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 291 | 206 | $107 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 249 | 207 | $76 | |
17000 |
Destruction of precancer skin growth, 1 growth | 247 | 200 | $39 | |
11102 |
Biopsy of related skin growth, first growth | 182 | 152 | $73 | |
17110 |
Destruction of skin growth, 1-14 growths | 181 | 147 | $95 | |
11103 |
Biopsy of related skin growth, each additional growth | 89 | 54 | $43 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | 23 | $1 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 39 | 39 | $140 | |
11900 |
Injection into skin growth, 1-7 growths | 34 | 25 | $40 |
In context: peer comparison
Among 54 peers in Marietta Physician Assistant, average services per provider: 75. This provider delivers 31× the peer median.Open Payments
Industry payments received
All-time total
$1,773
Transactions
67
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, INC. | 20 | $437.76 | |
| Abbvie INC. | 10 | $212.79 | |
| Novartis Pharmaceuticals Corporation | 3 | $162.96 | |
| Genzyme Corporation | 3 | $149.05 | |
| Janssen Biotech, INC. | 5 | $142.30 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $117.96 | |
| Amgen INC. | 4 | $107.20 | |
| Lilly USA, LLC | 3 | $73.66 | |
| Ucb, INC. | 3 | $55.67 | |
| Sun Pharmaceutical Industries INC. | 2 | $52.53 | |
| Almirall LLC | 2 | $52.05 | |
| Incyte Corporation | 2 | $45.81 | |
| Leo Pharma INC. | 2 | $44.24 | |
| Regeneron Healthcare Solutions, INC. | 1 | $35.65 | |
| Galderma Laboratories, L.P. | 2 | $33.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
608
Patients
411
Total drug cost
$419,077
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 113 | 92 | $2,062 |
| Clobetasol Propionate | Generic | 93 | 70 | $7,239 |
| Fluorouracil | Generic | 81 | 78 | $7,059 |
| Triamcinolone Acetonide | Generic | 79 | 70 | $686 |
| Metronidazole | Generic | 42 | 31 | $2,916 |
| Doxycycline Hyclate | Generic | 28 | 21 | $765 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 28 | 16 | $838 |
| Cosentyx Sensoready (2 Pens) (Secukinumab) | Brand | 22 | 0 | $165,555 |
| Dupixent Syringe (Dupilumab) | Brand | 22 | 0 | $85,069 |
| Dupixent Pen (Dupilumab) | Brand | 18 | 0 | $70,319 |
Frequently asked questions
What is Dr. Sarah Riley's medical specialty?
Dr. Sarah Riley practices Physician Assistant in Marietta, GA.
Where does Dr. Sarah Riley practice?
Dr. Sarah Riley practices at 835 Cogburn Avenue, Marietta, GA 300601008. Office phone: 7704225557.
What is Dr. Sarah Riley's NPI?
Dr. Sarah Riley's National Provider Identifier (NPI) is 1790338762, issued by NPPES.
Does Dr. Sarah Riley accept Medicare assignment?
Yes. Dr. Sarah Riley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sarah Riley commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.